Andon Health Co., Ltd.

Andon Health Co., Ltd. has seen a notable rise in its stock today, reaching an intraday high amid a modestly performing market. Over the past week, the company has demonstrated strong resilience, significantly outperforming the broader index, despite ongoing challenges reflected in declining sales and profits.

Andon Health Co. faced a notable decline in its stock price amid ongoing challenges, including a decrease in net sales and a significant drop in quarterly net profit. Despite strong long-term growth, the company has reported negative results for 13 consecutive quarters, raising concerns among investors.

Andon Health Co., Ltd. has seen a notable rise in its stock price, significantly outperforming the China Shanghai Composite index. Despite recent gains, the company faces challenges such as declining net sales and negative results over the past 13 quarters, while maintaining a market capitalization of CNY 30,991 million.

Andon Health Co., Ltd. faced a notable stock decline today amid ongoing challenges, with a significant drop in net sales and profit. Despite recent setbacks, the company has shown a year-over-year increase, contrasting with broader market trends. Its financial position remains complex, marked by a negative debt-equity ratio.

Andon Health Co., Ltd. has seen a significant rise today, contrasting with the modest gains of the China Shanghai Composite. Despite recent challenges, the company has shown impressive long-term growth, with substantial increases over the past year and five years, while facing ongoing negative quarterly results.

Andon Health Co., Ltd. saw its stock price decline significantly during a challenging trading session, reaching an intraday low. Despite recent short-term losses, the company has shown strong long-term growth. Financially, it reported a notable drop in net profit, while maintaining a relatively attractive valuation and dividend yield.

Andon Health Co. has seen a notable rise in its stock price, achieving a significant increase over the past week and a remarkable five-year growth. Despite recent challenges in net profit, the company maintains a strong market position with a competitive dividend yield and substantial market capitalization.

Andon Health Co., Ltd. faced a significant decline in stock value on June 17, 2026, reaching an intraday low. Despite this short-term volatility, the company has demonstrated strong long-term performance, with an 84.61% increase over the past year and a notable 769.05% rise over five years.

Andon Health Co. has shown strong market performance, gaining 5.84% on June 16, 2026, despite a slight decline in the China Shanghai Composite. The company has achieved impressive returns over the past year and year-to-date, while maintaining a high dividend yield and a favorable market valuation.

Andon Health Co., Ltd. has seen a notable increase in its stock price, reaching an intraday high while outperforming the broader market. Despite a recent decline, the company has shown substantial long-term growth. Key financial metrics indicate a favorable valuation, though it faces challenges with negative net profit growth.

Andon Health Co., Ltd. saw its stock price decline significantly, reflecting broader market trends. The company reported a notable drop in net sales and profit, continuing a streak of negative results over 13 quarters. Despite a year-to-date increase, recent performance has raised concerns about its financial stability.

Andon Health Co. faced a significant stock decline today, marking a 4.02% drop. Over the past week and month, the stock has decreased by 15.83% and 14.65%, respectively, outpacing the broader market. The company has reported ongoing financial challenges, including declining net sales and profits.

Andon Health Co. faced a significant stock decline, dropping 3.83% on June 8, 2026, amid a challenging market. The company reported a notable decrease in net sales and profit, raising concerns about its financial leverage. Despite strong year-to-date and five-year performance, recent metrics indicate underlying difficulties.

Andon Health Co. faced a notable decline in stock performance, dropping significantly today and over the past week. Despite strong year-to-date gains, recent financial metrics reveal a sharp decrease in net profit and sales, alongside a concerning debt-equity ratio, raising questions about its market position.

Andon Health Co., Ltd. faced a notable stock decline today, contrasting with a slight gain in the China Shanghai Composite. The company reported a significant drop in net sales and profit, continuing a negative trend over 13 quarters. Despite past long-term growth, current challenges reflect sector volatility.

Andon Health Co. has seen a notable rise in its stock price, achieving significant gains over various time frames. Despite impressive year-to-date performance, the company faces challenges, including declining net sales and profits, alongside a high debt-equity ratio, indicating potential financial strain amid its market success.

Andon Health Co., Ltd. has seen a notable increase in its stock price, reaching an intraday high amid mixed market conditions. Over the past year, the company has significantly outperformed the broader market, despite facing ongoing financial challenges, including declining net sales and profits.

Andon Health Co., Ltd. has shown remarkable stock performance, gaining 10.0% today and achieving an intraday high. Over the past week, the company has increased by over 10%, with a notable one-month gain of 54.63%. Despite challenges in operating profit, its year-to-date surge stands at 71.43%.

Andon Health Co., Ltd. saw a notable increase in its stock price on March 20, 2026, amid a declining broader market. The company has experienced significant gains over the past week and month, despite facing challenges in financial performance, including reduced operating profit and net sales.